Beta-thalassemia Major

4

Review clinical trials related to Beta-thalassemia Major. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

The Effect of Motivational Interviewing on Treatment Adherence and Self-Efficacy Among Omani Adults With Thalassemia

Beta-thalassemia major is a chronic hereditary blood disorder that requires lifelong treatment, including regular blood transfusions and iron chelation therapy. Poor adherence to treatment remains a significant challenge and may lead to iron overload and related complications. Self-efficacy is an important factor influencing patients' ability to adhere to treatment recommendations. This study aims to evaluate the effect of nurse-delivered Motivational Interviewing (MI) on treatment adherence and self-efficacy among Omani adults with beta-thalassemia major. A pre-experimental one-group repeated-measures design will be used. Approximately 45 participants will be recruited from the Oman National Center for Hematology and Bone Marrow Transplantation and Royal Hospital in Muscat, Oman. Participants will receive three individualized MI sessions over a period of six to eight weeks. Treatment adherence and self-efficacy will be assessed at baseline, immediately after completion of the intervention, and at three-month follow-up. Secondary outcomes include serum ferritin level and frequency of thalassemia-related hospital admissions. The findings will provide evidence regarding the usefulness of motivational interviewing in improving adherence-related outcomes among adults with beta-thalassemia major.

Participants needed: 45
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Oman Ministry of HealthUpdated: Jun 22, 2026
Eligibility criteria

Adults aged 18 years and older. [+6]

Current hospitalization for an acute medical condition at the time of recruitmen... [+3]

Status: Recruiting

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

The purpose of this study is to evaluate what effect, if any, mismatched unrelated volunteer donor and/or haploidentical related donor stem cell transplant may have on severe sickle cell disease and other transfusion dependent anemias. By using mismatched unrelated volunteer donor and/or haploidentical related donor stem cells, this study will increase the number of patients who can undergo a stem cell transplant for their specified disease. Additionally, using a T-cell depleted approach should reduce the incidence of graft-versus-host disease which would otherwise be increased in a mismatched transplant setting.

Participants needed: 5
Trial details
Phase: Phase 1, Phase 2Age: 5-40Biological sex: AllType: InterventionalSponsor: Paul SzabolcsUpdated: Aug 12, 2025Locations: 1
Eligibility criteria

Patient, parent, or legal guardian must have given written informed consent and/... [+21]

Patients with alternate, superior donor options (matched sibling donor or matche... [+5]

Status: Not yet recruiting

The Effect of Laughter Yoga in Beta Thalassaemia Major Patients: a Randomised Controlled Trial

The aim of this study was to evaluate the effects of laughter yoga on Fatigue, Depression-Anxiety-Stress, Sleep quality, Haematological values and Blood transfusion number in Beta Thalassemia Major patients.

Participants needed: 60
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Ataturk UniversityUpdated: May 20, 2025Locations: 1
Eligibility criteria

Diagnosed with Beta Thalassaemia major, [+7]

Who doesn't practice laughter yoga [+2]

Status: Recruiting

Inspiratory Muscle Training in Children With Beta Thalasemia

respiratory complications are very prevalent in children with beta thalasemia major (BTM), so choosing inspiratory muscle trianing to decrease of prevent it and to improve pulmoanry funntions is important

Participants needed: 40
Trial details
Age: 8-12Biological sex: AllType: InterventionalSponsor: Ahram Canadian UniversityUpdated: Jun 20, 2024Locations: 1
Eligibility criteria

40 beta thalassemia major children [+1]

respiratory diseases [+1]